Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment by helping the immune system better find and attack ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Key Takeaways Steroids appear to dampen the effectiveness of immunotherapy for lung cancerPeople who got steroids before or ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...

The NCCN has added taletrectinib to its recommendations for use in all lines of treatments for non–small cell lung cancer ...